Skip to main content
SpringerLink
Log in

Epidemiologic and Clinical Aspects of Opportunistic Infections

  • Chapter
Infections in the Immunocompromised Host

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 202))

Abstract

Infections in the immunocompromised host occur because of immune defects and epidemiological influences. They are often referred to as opportunistic infections, but many are caused by organisms, such as the pneumococcus, that infect apparently immunologically normal individuals. The infections are usually more severe in the immunocompromised host. There are, in addition, certain organisms such as Pneumocystis carinii that only infect immunocompromised individuals. In this paper, a clinical approach to the immunocompromised host is presented along with some selected features concerning therapy. With the exception of a few general references, the literature cited here reflects our experience at Memorial Sloan-Kettering Cancer Center (MSKCC).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J Verhoef, P.K. Peterson, and P.G. Quie, (Eds.), Infections in the immunocompromised host — Pathogenesis, Prevention, and therapy, in “Developments in Immunology,” New York, Elsevier/North Holland Biomedical Press, vol 11 (1983).

    Google Scholar 

  2. C.S.F. Easmon and H. Gaya (Eds), “Second International Symposium on Infections in the Immunocompromised Host,” Academic Press, Inc., New York (1983).

    Google Scholar 

  3. A.E. Brown and D. Armstrong, (Eds.), Controversies in the management of infectious complications of neoplastic disease, Amer.J. Med. 76:345–766 (1984).

    Article  Google Scholar 

  4. D. Armstrong, Infections in patients with neoplastic disease in “Infections in the Immunocompromised Host — Pathogenesis, Prevention, and Therapy,” J. Verhoef, et al., (eds.), pp. 129–158 (1980).

    Google Scholar 

  5. R.D. Meyer, Legionnaire’s Disease. Aspects of nosocomical infection, in “Controversies in the Management of Infectious Complications of Neoplastic Disease,” A.E. Brown and D. Armstrong, eds., Amer. J. Med. 76:657–663 (1984).

    Google Scholar 

  6. D. Armstrong, Fungal infections in the compromised host, in “Clinical Approach to Infection in the Compromised Host,” R.H. Rubin & L.S. Young, eds., Plenum Medical, New York, pp. 195–288 (1981).

    Google Scholar 

  7. D. Armstrong and B. Wong, Central nervous system infections in immunocompromised hosts, Ann. Rev. Med. 33:293–308 (1982).

    Article  PubMed  CAS  Google Scholar 

  8. S.A. Lukes, J.B. Posner, S. Nielsen, and D. Armstrong, Bacterial infections of the CNS in neutropenic patients, Neurol. 34:269–275 (1984).

    Article  CAS  Google Scholar 

  9. M.J. Gersten, F. Ognibene, A. Blevins, and D. Armstrong, Listeria infections and neoplastic disease. An old association, recent observations, In preparation.

    Google Scholar 

  10. B.P. Polsky, and D. Armstrong, Cryptococcosis, In preparation

    Google Scholar 

  11. T.B. Hakes, and D. Armstrong, Toxoplasmosis: Problems in diagnosis and treatment, Cancer 52:1535–1540 (1983).

    Article  PubMed  CAS  Google Scholar 

  12. B. Wong, J.W.M. Gold, A.E. Brown, M. Lange, R. Fried, M. Grieco, D. Mildvan, J. Giron, M.L. Tapper, C.N. Lerner and D. Armstrong, Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers in New York: high incidence of infection and abnormal antibody responses, Ann. Intern. Med. 100:36–42 (1984).

    PubMed  CAS  Google Scholar 

  13. B. Fisher, D. Armstrong, B. Yu and J.W.M. Gold, Invasive aspergillos: Progress in early diagnosis and treatment, Amer.J.Med. 71:571–577 (1981).

    Article  PubMed  CAS  Google Scholar 

  14. J.C. Schaefer, B. Yu and D. Armstrong, An aspergillus immunodiffusion test in the early diagnosis of aspergillosis in adult leukemia patients, Amer. Rev. Resp. Dis. 113:325–329 (1976).

    PubMed  CAS  Google Scholar 

  15. M.H. Weiner, G.H. Talbot, S.L. Gerson, G. Filice and P.A. Cassileth, Antigen detection in the diagnosis of invasive aspergillosis, Ann. Intern. Med. 99:777–782 (1983).

    PubMed  CAS  Google Scholar 

  16. H. Mazur, P.P. Rosen, and D. Armstrong, Pulmonary disease caused by Candida species, Amer.J.Med. 63:914–925 (1977).

    Article  Google Scholar 

  17. R. Horn, B. Wong, T.E. Kiehn, and D. Armstrong, Fungemia in a cancer hospital: increasing frequency, earlier onset and results of therapy in 188 patients. Submitted for publication.

    Google Scholar 

  18. L.S. Young, D. Armstrong, A. Blevins, and P. Lieberman, Nocardia asteroides infection complicating neoplastic disease, Amer.J.Med. 50:356–367 (1971).

    Article  PubMed  CAS  Google Scholar 

  19. R. Berg, H. Chmel, J. Mayo and D. Armstrong, Corynebacterium equi infection complicating neoplastic disease, Amer.J.Clin.Pathol. 68:73–77 (1977).

    CAS  Google Scholar 

  20. B.D. Fisher and D. Armstrong, Cryptococcal interstitial pneumonia: Value of antigen determination, New Engl. J. Med. 97:1440–1441 (1977).

    Article  Google Scholar 

  21. D.E. Stover, S.I. Hajdu, M.B. Zaman, M.L. Lange, J.W.M. Gold, and D. Armstrong, Bronchoaveolar lavage and the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host, Annal. Intern. Med. 101:1–7 (1984).

    CAS  Google Scholar 

  22. J.W. Wynne and D. Armstrong, Clostridial septicemia, Cancer 29:215–221 (1982).

    Article  Google Scholar 

  23. E. Whimbey and D. Armstrong, Bacteremia and fungemia in patients with neoplastic disease. In preparation.

    Google Scholar 

  24. F.M. Carpentier, T.E. Kiehn and D. Armstrong, Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality, Amer.J.Med. 71:363–370 (1981).

    Article  Google Scholar 

  25. E. Goldstein and P.D. Hoeprich, Problems in the diagnosis and treatment of systemic candidiasis, J. Infect. Dis. 125:190–193 (1972).

    Article  PubMed  CAS  Google Scholar 

  26. T.E. Kiehn, B. Wong, F.F. Edwards and D. Armstrong, Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system; J.Clin. Microbiol. 18:300–304 (1983).

    PubMed  CAS  Google Scholar 

  27. G. Filice, B. Yu and D. Armstrong, Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: Inconsistent correlation of results with invasive infections, J.Infect.Dis. 135:349–357 (1977).

    Article  PubMed  CAS  Google Scholar 

  28. M.H. Meiner and W.J. Young, Mannan antigenemia in the diagnosis of invasive Candida infections, J.Clin.Invest. 58:1045–1053 (1976).

    Article  Google Scholar 

  29. F.M. Carpentier and D. Armstrong, Candida antigenemia as detected by passive hemagglutination inhibition in patients with disseminated Candidiasis or Candida colonization, J.Clin.Microbiol. 13:10–14 (1981).

    Google Scholar 

  30. M.A. Lew, G.R. Siber, D.M. Donahue, and F. Maiorca, Enhanced detection with an enzyme linked immunosorbent assay of Candida mannan in antibody containing serum after heat extraction, J.Infect. Dis. 145:45–56 (1981).

    Article  Google Scholar 

  31. P. Stevens, S. Huang, L.S. Young, and M. Berdischewsky, Detection of Candida antigenemia in human invasive Candidiasis by a new solid phase radioimmunoassay, Infection 8: (Suppl. 3) 5334–5338 (1980).

    Article  Google Scholar 

  32. G.G. Miller, M.W. Witwer, A.I. Braude, and C.E. Davis, Rapid identification in man by gas-liquid chromatography, J.Clin.Invest. 54:1236–1240 (1974).

    Article  Google Scholar 

  33. E.M. Bernard, K.J. Christiansen, S. Tsang, T.E. Kiehn, and D. Armstrong, Rate of arabinitol production by pathogenic yeast species, J. Clin. Microbiol. 14:189–194 (1981).

    PubMed  CAS  Google Scholar 

  34. T.E. Kiehn, E.M. Bernard, J.W.M. Gold and D. Armstrong, Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum, Science 206:577–580 (1979).

    Article  PubMed  CAS  Google Scholar 

  35. J. Roboz, R. Susuki, and J.F. Holland, Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive Candidiasis, J.Clin. Microbiol. 12:594–602 (1980).

    PubMed  CAS  Google Scholar 

  36. B. Wong, E. Bernard, J. Gold, D. Fong and D. Armstrong, The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatinine ratio and relevance to the diagnosis of Candiasis, J.Infect.Dis. 146:353–3590 (1982).

    Article  PubMed  CAS  Google Scholar 

  37. B. Wong, E.M. Bernard, J.W.M. Gold, A. Silber and D. Armstrong, Increased arabinitol levels in experimental Candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection, J.Infect.Dis. 146:346–352 (1982).

    Article  PubMed  CAS  Google Scholar 

  38. J.W.M. Gold, B. Wong, E.M. Bernard, T.E. Kiehn and D. Armstrong, Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive Candidiasis, J.Infect.Dis. 147:504–514 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. B. Wong, F.F. Edwards, T.E. Kiehn, E. Whimbey, H. Donnelly, E.M. Bernard, J.W.M. Gold and P. Armstrong, Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with the acquired immunodeficiency syndrome. Submitted for Publication, 1984.

    Google Scholar 

  40. P.A. Pizzo, K.J. Robichaud, F.A. Gill, F.G. Witebsky, A.S. Levine, A.B. Deisseroth, P.L. Glaubiger, J.D. Maclowry, I.T. Magrath, D.G. Poplack, and R.M. Simon, Duration of empiric antibiotic therapy in granulocytopenic patients with cancer, Amer.J.Med. 67:194–200 (1979).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Service of the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Donald Armstrong

Authors
  1. Donald Armstrong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Smith Kline and French Laboratories, Philadelphia, Pennsylvania, USA

    Paul Actor

  2. Cooper Hospital, University Medical Center, Camden, New Jersey, USA

    Alan Evangelista

  3. Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, USA

    James Poupard

  4. Rolling Hill Hospital, Elkins Park, Pennsylvania, USA

    Eileen Hinks

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Armstrong, D. (1986). Epidemiologic and Clinical Aspects of Opportunistic Infections. In: Actor, P., Evangelista, A., Poupard, J., Hinks, E. (eds) Infections in the Immunocompromised Host. Advances in Experimental Medicine and Biology, vol 202. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1259-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1259-8_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1261-1

  • Online ISBN: 978-1-4684-1259-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation